NIR-to-NIR upconversion nanoparticle-based lateral flow immunoassay platform

Item Number: 627
Industry: Platform
Category: Diagnostic / Imaging
Development Stage: Early Stage
Organisation Type: Government Institute
Country: South Korea
Patent: Korea, PCT
Business Opportunity: Out-Licensing


The present invention relates to a rapid and background-free lateral flow immunoassay (LFA) platform that utilizes near-infrared (NIR)-to-NIR upconversion nanoparticles (UCNPs) 

Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it